Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study.

Weber DG, Johnen G, Bryk O, Jöckel KH, Brüning T.

PLoS One. 2012;7(1):e30221. doi: 10.1371/journal.pone.0030221. Epub 2012 Jan 11.

PMID:
22253921
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma.

Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, Pozzi V, Carbonari D, Bracci M, Pignotti E, Mazzanti P, Sabbatini A, Ranaldi R, Gasparini S, Neuzil J, Tomasetti M.

PLoS One. 2011 Apr 1;6(4):e18232. doi: 10.1371/journal.pone.0018232.

PMID:
21483773
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

Kirschner MB, Cheng YY, Badrian B, Kao SC, Creaney J, Edelman JJ, Armstrong NJ, Vallely MP, Musk AW, Robinson BW, McCaughan BC, Klebe S, Mutsaers SE, van Zandwijk N, Reid G.

J Thorac Oncol. 2012 Jul;7(7):1184-91. doi: 10.1097/JTO.0b013e3182572e83.

PMID:
22617246
[PubMed - indexed for MEDLINE]
4.

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O.

J Transl Med. 2012 Mar 22;10:55. doi: 10.1186/1479-5876-10-55.

PMID:
22440013
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.

Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC.

PLoS One. 2012;7(3):e33608. doi: 10.1371/journal.pone.0033608. Epub 2012 Mar 14.

PMID:
22432036
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S.

PLoS One. 2010 Oct 29;5(10):e13735. doi: 10.1371/journal.pone.0013735.

PMID:
21060830
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study.

Amati M, Tomasetti M, Scartozzi M, Mariotti L, Alleva R, Pignotti E, Borghi B, Valentino M, Governa M, Neuzil J, Santarelli L.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):163-70. doi: 10.1158/1055-9965.EPI-07-0607.

PMID:
18199721
[PubMed - indexed for MEDLINE]
Free Article
8.

Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.

Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H.

Cancer Lett. 2012 Mar 28;316(2):196-203. doi: 10.1016/j.canlet.2011.10.034. Epub 2011 Nov 2.

PMID:
22169097
[PubMed - indexed for MEDLINE]
9.

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.

Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.

PMID:
19396864
[PubMed - indexed for MEDLINE]
10.

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.

Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G.

Am J Respir Cell Mol Biol. 2010 Mar;42(3):312-9. doi: 10.1165/rcmb.2009-0060OC. Epub 2009 Jun 5.

PMID:
19502386
[PubMed - indexed for MEDLINE]
11.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

PMID:
22242178
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.

Creaney J, Olsen NJ, Brims F, Dick IM, Musk AW, de Klerk NH, Skates SJ, Robinson BW.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2238-46. doi: 10.1158/1055-9965.EPI-10-0346. Epub 2010 Jul 22.

PMID:
20651076
[PubMed - indexed for MEDLINE]
Free Article
13.

Circulating microRNAs as specific biomarkers for breast cancer detection.

Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.

PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3.

PMID:
23301032
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, ElDirani R, Berri F, Vanhamme L, Burny A, Martiat P, Rouas R, Badran B.

J Transl Med. 2013 Feb 7;11:31. doi: 10.1186/1479-5876-11-31.

PMID:
23391324
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.

Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.

Int J Cancer. 2013 Jan 1;132(1):116-27. doi: 10.1002/ijc.27657. Epub 2012 Jun 26.

PMID:
22674182
[PubMed - indexed for MEDLINE]
16.

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.

Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass HI.

PLoS One. 2012;7(10):e46091. doi: 10.1371/journal.pone.0046091. Epub 2012 Oct 3.

PMID:
23056237
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C.

N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050. Erratum in: N Engl J Med. 2012 Nov;367(18):1768.

PMID:
23050525
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.

Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, Li N, Tang B, Liu KY, Xiao B.

PLoS One. 2012;7(7):e41629. doi: 10.1371/journal.pone.0041629. Epub 2012 Jul 30.

PMID:
22860003
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients.

Tomasetti M, Staffolani S, Nocchi L, Neuzil J, Strafella E, Manzella N, Mariotti L, Bracci M, Valentino M, Amati M, Santarelli L.

Clin Biochem. 2012 May;45(7-8):575-81. doi: 10.1016/j.clinbiochem.2012.02.009. Epub 2012 Feb 21.

PMID:
22374169
[PubMed - indexed for MEDLINE]
20.

Decreased serum miR-181a is a potential new tool for breast cancer screening.

Guo LJ, Zhang QY.

Int J Mol Med. 2012 Sep;30(3):680-6. doi: 10.3892/ijmm.2012.1021. Epub 2012 Jun 11.

PMID:
22692639
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk